- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Dr. Reddy's Laboratories Limited — Updates, 14-01-2026: Press Release
14-01-2026 | 04:44 pm
14-01-2026 | 04:44 pm
Dr. Reddy's launched a first-to-market generic eye drop, Olopatadine Hydrochloride Ophthalmic Solution 0.7%, in the U.S. It targets Extra-Strength Pataday®, a product with ~$6.99 Cr in annual sales, expanding Dr. Reddy's OTC eye-care portfolio.
No comments yet. Be the first to comment!